BLOG / 🇮🇳 India / index intelligence · · daily

BSE FMCG Sector Regulatory Filings — November 04, 2026

India BSE FMCG

By Gunpowder Editorial ·

5 high priority 17 medium priority 22 total filings analysed

Executive Summary

The 22 filings are dominated by Dabur India (13 filings) and Hindustan Unilever (3), with Varun Beverages, Godrej Consumer Products, ITC, Britannia and Radico Khaitan providing the rest.

Growth is strong on the headline: Dabur reported Q2 FY27 consolidated revenue of Rs 3,563 Cr (+11.6% YoY, but -5.3% QoQ) and PAT of Rs 505 Cr (+11.7% YoY), with an interim dividend of Rs 3.50/share (record date 10 Nov 2026). HUL posted 15% USG and 7% UVG, its strongest USG in 14 quarters, yet reported PAT was flat YoY and gross margin contracted roughly 400 bps. Varun Beverages showed 33.2% revenue growth but gross margin fell 334 bps YoY to 53.1% on packaging inflation, with management calling Q3 CY2026 the likely margin trough. Godrej Consumer grew consolidated revenue 19% but flagged a softer Personal Care segment and higher Q3 commodity inflation. The dominant portfolio pattern is volume-light, price-led growth alongside input-cost pressure, with Dabur's leadership transition the main governance development. No insider trading, pledge or buyback data was present in these filings.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Company update · Corporate governance · Corporate action

Tracking the trend? Catch up on the prior BSE FMCG Sector Regulatory Filings digest from November 03, 2026.

Investment Signals (10)

  • September 2026 quarter USG of 15% and UVG of 7%, the strongest USG in 14 quarters, with PAT before exceptionals up 9% to Rs 2,795 Cr; medium-term EBITDA margin range reiterated at 22-24%

  • ▲

    Q3 CY2026 revenue +33.2% YoY to Rs 66,076 Mn and EBITDA +25.1% to Rs 14,267 Mn (21.6% margin); management says gross margin is likely at trough, with over half of the 3-4% impact already mitigated

  • ▲

    Q2 FY27 consolidated PAT Rs 505 Cr (+11.7% YoY), the fourth consecutive quarter of double-digit profit growth; H1 PAT Rs 1,096 Cr (+13.4%)

  • ▲

    Interim dividend of Rs 3.50/share (Rs 620.88 Cr) declared, record date 10 Nov 2026, payment from 25 Nov 2026, signalling continued shareholder returns

  • ▲

    General Trade channel resurged to mid-to-high single-digit growth in Q2, and International grew 20% and F&B 17.4% in INR terms

  • Q2 FY27 consolidated revenue +19% YoY (15% constant currency), 8% underlying volume growth, net profit +14% to Rs 523 Cr; FY27 double-digit consolidated revenue and EBITDA growth guidance held

  • Gross margin down roughly 400 bps and EBITDA margin down 140 bps to 22.6%, with management pointing to a lag between input-cost inflation and pricing

  • ▲

    Healthcare grew only 6.9% in Q2 (slowest major segment) and Honey declined mid-single digit; Oral Care grew only mid-single digits

  • ▲

    Depreciation (+34.5%) and finance costs (+53.5%) rose sharply after the Twizza acquisition, and other income fell 18.8%, weighing on PAT growth to 13.5%

  • ▲

    Consolidated profit attributable to owners fell 5.2% QoQ and revenue fell 5.3% QoQ in Q2, showing sequential softness behind the YoY headline

Risk Flags (8)

  • Global CEO and Whole-time Director Mohit Malhotra resigns effective 13 Nov 2026, but his letter cites an overseas role from 16 Nov and asks to be relieved earlier; the effective-date discrepancy needs clarification, and Herjit Singh Bhalla's appointment is subject to postal ballot

  • Gross margin contracted about 400 bps YoY, with Home Care A&P cut by about Rs 250 Cr while spend rose elsewhere; reported PAT was flat YoY because of a Rs 273 Cr one-off tax gain in the base period

  • ▼

    'Others' other expenses rose 23.6% YoY to Rs 504.62 Cr, total expenses rose 12.0% YoY, and management flagged elevated input-cost pressures and geopolitical uncertainty as ongoing headwinds

  • Healthcare growth of 6.9% and honey decline in the mid-single digits on a high base, partly due to FSSAI labelling order disruption; Retail remains loss-making at Rs (1.86) Cr segment result

  • UK international business declined 33.3% YoY (constant currency -38.7%), a material drag within the International segment

  • Gross margin headwind of about 300 bps from packaging and about 100 bps from non-beverage sales in India; the Sting pack was downsized from 300 ml to 250 ml

  • Personal Care value growth of only 8% on trade inventory correction, soap price-volume recalibration and weaker soap volumes; Q3 commodity inflation expected to be higher than Q2

  • Consolidated finance costs rose to Rs 39.59 Cr in Q2 from Rs 36.63 Cr in Q1, a sequential increase in the debt-service burden

Opportunities (7)

  • Premium brands grow at about 4x regular brands within Dabur's domestic business and HUL shows 3.5x-6x nearest-competitor share multiples across major categories (Nielsen MAT Sep'26), supporting pricing power as input costs normalise

  • Management says Q3 CY2026 is likely the gross-margin trough, with more than half of the 3-4% impact already offset through cost reductions; a recovery in margin would lift EBITDA growth from the 25.1% base

  • Management cited about 260 bps of EBITDA offset from overheads and A&P operating leverage, and a medium-term margin range of 22-24% has been raised 50 bps each side, indicating scope for margin rebuild

  • General Trade resurged to mid-to-high single-digit growth and International and F&B grew 20% and 17.4%, offering diversified growth drivers beyond Healthcare

  • 8% underlying volume growth and FY27 guidance for high single-digit standalone UVG and double-digit consolidated revenue and EBITDA growth; the trade-inventory correction is a one-off that should unwind

  • ◆

    Interim dividend of Rs 3.50 per share (350% of Rs 1 face value) for FY27 provides an immediate cash return ahead of the 10 Nov record date

  • Remuneration cap for non-executive directors proposed at Rs 15 Cr or 1% of net profit, with postal ballot results due 19 Dec 2026, a clear near-term governance event

Sector Themes (5)

  • Volume-Light Growth Across FMCG
    ◆

    Dabur India's India FMCG UVG of 5.5% versus 10.7% headline growth, and HUL's 7% UVG against 15% USG, show that roughly half or more of top-line growth is price/mix-driven; the pattern holds across Dabur, HUL and Godrej Consumer Products [IMPLICATION: volume recovery is the key test for sustainability]

  • Input-Cost Lag and Gross Margin Compression
    ◆

    HUL gross margin down roughly 400 bps, Varun Beverages down 334 bps, and Godrej flagging higher Q3 commodity inflation; management in multiple filings attributes the gap to a lag between cost inflation and pricing, pointing to margin recovery only once pricing catches up [IMPLICATION: margin trough timing is the main sector swing factor]

  • Premiumisation and Mix Shift
    ◆

    Dabur premium brands at 20% of domestic business growing 4x regular brands, and HUL's 3.5x-6x category share leadership, underline a mix-led growth strategy within FMCG [IMPLICATION: premium mix supports margin structure]

  • Quick Commerce and Channel Diversification
    ◆

    HUL quick commerce above 50% USG, HUL open-format store strength, and Dabur General Trade resurgence indicate channel evolution beyond traditional distribution [IMPLICATION: channel mix is shaping growth quality]

  • Governance and Leadership Transition
    ◆

    Dabur's CEO exit, new whole-time director, CFO also taking Compliance Officer role, new Lead Independent Director from 1 Jan 2027 and joint internal auditor appointments show a company-wide board refresh [IMPLICATION: continuity risk and execution transition]

Watch List (8)

Filing Analyses (22)
Hindustan Unilever Limited Market Notice positive materiality 4/10

04-11-2026

Hindustan Unilever Limited filed an investor presentation under Regulation 30 of the SEBI LODR Regulations, to be made at an upcoming analyst/institutional investor meet. The deck positions India FMCG as a large runway for growth and highlights underlying sales growth accelerating across recent quarters, with quick commerce showing over 50% USG and open-format and health & beauty store initiatives reporting strong per-store growth. The filing contains no reported financial results, so the deck's figures are management's operating metrics rather than audited statements.

  • · Underlying volume growth is cited alongside underlying sales growth as a driver of the volume-led revenue story, with the quarterly USG chart spanning SQ'25 to SQ'26.
  • · Management frames the Indian market as having a 60X+ relative consumption gap versus Indonesia-type penetration in laundry soaps, indicating long-term headroom claims that are not quantified as HUL-specific targets.
  • · Market leadership claims include 3.5x to 6x nearest-competitor share multiples across hair care, skin care, skin cleansing, laundry, dishwash and lifestyle/nutrition categories (Nielsen MAT Sep'26).
  • · Management cites 'Employer of Choice' (#1) based on an InsideIIM brand perception study of top Indian B-schools in 2025.
  • · Advantage Survey rank #2 for quick commerce partners Blinkit and Swiggy Instamart is cited as a performance benchmark.
  • · The deck identifies eight multi-year strategic bets, including scaling home care liquids and building masstige beauty and superfood nutrition positions.
ITC Limited Company Update neutral materiality 2/10

04-11-2026

ITC Limited has disclosed under Regulation 30 of the SEBI LODR Regulations that its representatives will attend two investor forums: the 29th CITIC CLSA India Forum 2026 in Mumbai on 16 November 2026 (organised by CLSA India Private Limited) and Morgan Stanley's 25th Annual Asia Pacific Summit in Singapore on 18-19 November 2026, with physical one-to-one meetings with investors. The filing contains no financial results, guidance, or quantitative performance data.

  • · CLSA India Forum event on 16 November 2026 in Mumbai is physical attendance at the 29th edition
  • · Morgan Stanley 25th Annual Asia Pacific Summit on 18-19 November 2026 in Singapore includes physical one-to-one investor meetings
  • · Filing copied to the US SEC Division of Corporate Finance and the Luxembourg Stock Exchange, indicating ITC's listing/reporting footprint beyond India
Varun Beverages Limited Analyst/Investor Meet mixed materiality 7/10

04-11-2026

Varun Beverages reported strong Q3 CY2026 results with revenue from operations up 33.2% YoY to Rs. 66,076 million, EBITDA up 25.1% to Rs. 14,267 million (21.6% margin), and PAT up 13.5% to Rs. 8,306 million. However, gross margin contracted 334 bps YoY to 53.1% on packaging cost inflation from geopolitical disruptions, and depreciation and finance costs rose 34.5% and 53.5% respectively following the Twizza acquisition; other income declined 18.8%. The call transcript was filed under Regulation 30 on November 4, 2026, covering the call held October 30, 2026.

  • · Gross margin headwind of approximately 300 bps from packaging costs and approximately 100 bps from non-beverage sales in India; management said more than half of the 3-4% gross margin impact has been mitigated through cost reductions
  • · Management indicated Q3 CY2026 gross margins are likely the trough, subject to no further macro surprises
  • · Sting pack size reduced from 300 ml to 250 ml; Rs. 10 price point (150 ml) constitutes only 0.2-0.3% of overall volume
  • · International capex for CY2027 approximately $90-100 million; India capex approximately Rs. 1,000 crore
  • · Management expects to add a couple of hundred thousand outlets per year; Zimbabwe Mondelez partnership builds on existing approximately $11 million Mondelez business
  • · Energy drink category (Sting) volumes recovering after FSSAI labelling ruling restricting use of 'energy' on labels
  • · Management plans RTD entry and is in talks with global alcobev partners, with focus on higher-margin premium portfolio
  • · October 2026 quarter trends not commented on; management said quarter still in progress
Dabur India Limited Corporate Governance mixed materiality 6/10

04-11-2026

Dabur India reported consolidated revenue from operations of ₹7327.46 Crore for H1 FY27 (half year ended 30 September 2026), up about 11.1% from ₹6595.90 Crore a year earlier, and consolidated net profit attributable to owners of ₹1096.38 Crore, up about 13.5%. For Q2 (quarter ended 30 September 2026), consolidated revenue of ₹3563.07 Crore grew about 11.6% year-on-year, but it declined about 5.3% quarter-on-quarter from ₹3764.39 Crore, and profit after tax of ₹498.57 Crore was up only about 12.1% year-on-year while falling about 14.9% sequentially. The Board declared an interim dividend of ₹3.50 per share aggregating ₹620.88 crore (record date 10 November 2026), and NCLT approved the amalgamation of Sesa Care Private Limited with the company.

  • · Standalone Q2 revenue from operations was ₹2432.87 Crore, up about 8.9% YoY but down about 9.5% QoQ, and standalone net profit was ₹387.84 Crore, up about 11.2% YoY but down about 14.3% QoQ
  • · Consumer care business segment revenue was ₹2953.29 Crore in Q2, up about 11.4% YoY but down about 1.6% QoQ; food business revenue of ₹531.38 Crore grew about 14.1% YoY but fell about 19.4% QoQ
  • · Retail business revenue was ₹26.77 Crore in Q2, up about 7.2% YoY but down about 4.5% QoQ, and remained loss-making at a segment result of ₹(1.86) Crore
  • · Q2 consolidated segment assets rose to ₹17869.03 Crore at 30 September 2026 versus ₹17479.91 Crore at 31 March 2026
  • · Consolidated debt-equity ratio was 0.13 and debt-to-total-assets ratio was 8.08%, while the current ratio was 1.63
  • · Trade receivables increased to ₹1060.30 Crore from ₹715.41 Crore at 31 March 2026, a rise of about 48%, while cash and cash equivalents fell to ₹133.06 Crore from ₹199.37 Crore
  • · Operating margin in Q2 was 17.75%, down from 19.69% in the preceding quarter and 18.43% a year earlier
Dabur India Limited Market Notice mixed materiality 6/10

04-11-2026

Dabur India Limited reported Q2 FY27 consolidated revenue of ₹3,563 Crore, up 11.6% YoY, and consolidated PAT of ₹505 Crore, up 11.7% YoY, marking its fourth consecutive quarter of double-digit profit growth. The company also declared an interim dividend of ₹3.50 per share, aggregating ₹620.88 Crore. Growth was mixed across segments: Healthcare grew a comparatively modest 6.9%, while International grew 20% and F&B grew 17.4%.

  • · Healthcare grew only 6.9% in Q2, the slowest of the reported segments, despite strong double-digit growth in Digestives, OTC and Ethicals
  • · India FMCG underlying volume growth was 5.5%, meaning roughly half of the 10.7% FMCG growth came from price/mix
  • · Premium brands held a 20% share of the domestic business, unchanged from the stated share, while growing at 4x regular brands
  • · General Trade showed a marked resurgence, growing in the mid to high single digits in the quarter
  • · Management cited geopolitical uncertainty and elevated input-cost pressures as headwinds
Britannia Industries Limited Market Update neutral materiality 1/10

04-11-2026

Britannia Industries Limited has informed the stock exchanges that its Registrar to an Issue and Share Transfer Agent, KFin Technologies Limited, will shift its Corporate Office to a new address in Hyderabad, Telangana, effective 1 December 2026. Shareholders and other stakeholders are asked to send all future correspondence and documents to the new address from that date, while the RTA's toll-free number, email, website and investor support centre remain unchanged. This is an administrative notice with no financial impact.

  • · New RTA corporate office: Selenium Building, Tower-B, Financial District, Nanakramguda, Hyderabad - 500 032, Telangana, effective 1 December 2026
  • · Previous RTA corporate office: Rajapushpa West Avenue, Kokapet, Ranga Reddy District - 500 075, Telangana
  • · RTA toll-free number 1800 309 4001 and email [email protected] remain unchanged
  • · RTA notified the Company of the address change on 3 November 2026
Dabur India Limited Market Notice mixed materiality 6/10

04-11-2026

Dabur India Limited filed its investor presentation for the quarter ended September 2026 (Q2 FY27). Consolidated revenue rose 11.6% YoY to INR 3,563 Cr and PAT grew 11.7% to INR 505 Cr, while consolidated operating profit grew 7.5% to INR 633 Cr with margins contracting 60 bps. Standalone revenue grew 8.9% to INR 2,433 Cr and standalone PAT grew 11.2% to INR 388 Cr, but growth was mixed across segments: honey declined mid-single digit and health supplements declined low single digit, while India FMCG volume growth was 5.5%.

  • · Honey declined mid-single digit on a high base, partly impacted by temporary trade sentiment disruption following an FSSAI labeling-related order
  • · Health Supplements segment declined low single digit
  • · UK international business declined 33.3% (constant currency -38.7%)
  • · Consolidated operating margin contracted 60 bps YoY to 17.8%
  • · Consolidated advertisement and publicity expense fell 3.0% YoY
  • · Hair oils and shampoo grew high teens; Foods grew strong double digit; Digestives grew strong double digit
  • · Consolidated net profit margin was flat YoY at 14.2%
  • · Dabur Honitus and Health Juices (OTC & Ethicals) grew mid-teens and high-teens respectively
Radico Khaitan Limited Market Update neutral materiality 1/10

04-11-2026

Radico Khaitan Limited disclosed that its Registrar and Share Transfer Agent, KFin Technologies Limited, will relocate its Corporate Office effective December 1, 2026, from Gachibowli, Hyderabad to Kokapet, Hyderabad. The Registered Office of the RTA is unchanged, and investors are asked to update their records accordingly. This is an administrative notice with no financial impact on the company.

  • · Effective date of the RTA office relocation is December 1, 2026
  • · New RTA Corporate Office: 6th, 23rd, 24th, 25th Floor, South Tower, West Avenue, Survey No. 115, Kokapet, Serilingampally Mandal, Ranga Reddy District, Hyderabad - 500075
  • · Prior RTA Corporate Office: Selenium Tower B, Plot No. 31 & 32, Gachibowli, Financial District, Nanakramguda, Hyderabad - 500032
  • · KFin's intimation to the company is dated November 3, 2026
Dabur India Limited Corporate Action mixed materiality 6/10

04-11-2026

Dabur India Limited reported consolidated revenue from operations of ₹7327.46 Crore for H1 FY27 (half year ended 30 September 2026), up about 11.1% from ₹6595.90 Crore in the corresponding prior-year half, and consolidated net profit of ₹1084.73 Crore, up about 13.8% from ₹953.08 Crore. For Q2, revenue from operations rose about 11.7% YoY to ₹3563.07 Crore, while net profit grew about 12.1% to ₹498.57 Crore. Growth was uneven: the Food business revenue rose about 9.6% YoY for the half, but Retail business revenue (₹54.79 Crore) and Other segments margin were small, and Q2 consolidated revenue declined about 5.4% sequentially versus Q1. The Board declared an interim dividend of ₹3.50 per share aggregating ₹620.88 Crore with a record date of 10 November 2026.

  • · Standalone revenue from operations for H1 FY27 was ₹5120.21 Crore, up about 8.9% YoY, and standalone net profit was ₹840.25 Crore, up about 11.2% YoY
  • · Consolidated Retail business revenue was flat-to-weak at ₹54.79 Crore for the half year, with segment results still negative at ₹(2.55) Crore
  • · Standalone Q2 revenue declined about 9.4% sequentially versus Q1 FY27
  • · NCLT approved the amalgamation of Sesa Care Private Limited with effect from an appointed date of 01 April 2026, effective on filing with the ROC
  • · Final dividend of ₹975.67 Crore (₹5.50 per share) for FY2025-26 was paid in Q2 FY27
Dabur India Limited Market Notice mixed materiality 7/10

04-11-2026

Dabur India Limited reported Q2 FY27 consolidated revenue of ₹3,563 Crore, up 11.6%, and Q2 net profit (PAT) of ₹505 Crore, up 11.7%, marking its fourth consecutive quarter of double-digit profit growth. Half-year revenue reached ₹7,327 Crore (+11.1%) and half-year PAT ₹1,096 Crore (+13.4%). The Board declared an Interim Dividend of ₹3.50 per share, aggregating ₹620.88 Crore. Growth was uneven across segments: the India FMCG business grew 10.7%, the Healthcare business grew only 6.9%, and the Food & Beverages business grew 17.4%, while the International business grew 20% in INR terms.

  • · Healthcare business grew only 6.9% in Q2, the slowest of the major segments, despite strong double-digit growth in Digestives, OTC and Ethicals
  • · India FMCG underlying volume growth was 5.5%, implying most of the 10.7% growth came from price/mix
  • · General Trade channel grew mid-to-high single digits, marking a resurgence
  • · Premium brands account for 20% of the domestic business and grew at 4x the pace of regular brands
  • · Management cited geopolitical uncertainty and elevated input-cost pressures as external challenges
Dabur India Limited Market Notice positive materiality 6/10

04-11-2026

Dabur India Limited reported Q2 FY27 consolidated revenue of ₹3,563 Crore, up 11.6% YoY, and Q2 net profit (PAT) of ₹505 Crore, up 11.7% YoY, marking its fourth consecutive quarter of double-digit profit growth. The Board also declared an interim dividend of ₹3.50 per share, aggregating ₹620.88 Crore. Performance was broad-based, though management flagged geopolitical uncertainty and elevated input-cost pressures as headwinds.

  • · Healthcare grew only 6.9%, the slowest of the reported segments, while Food & Beverages grew 17.4% with a sequential recovery in Beverages.
  • · Oral Care grew only mid-single digits and Skin & Salon grew high single digit, both trailing the company's double-digit headline growth.
  • · Management flagged geopolitical uncertainty and elevated input-cost pressures as ongoing headwinds to the outlook.
  • · General Trade channel resurgence to mid-to-high single-digit growth is credited partly to Project Saksham.
Dabur India Limited Corporate Action mixed materiality 7/10

04-11-2026

Dabur India Limited's Board approved unaudited consolidated and standalone results for the quarter and half year ended September 30, 2026, with an unmodified limited review opinion from the statutory auditor. Consolidated revenue from operations for Q2 FY27 was ₹3,563.07 Cr, up 11.6% YoY from ₹3,191.32 Cr but down 5.3% QoQ from ₹3,764.39 Cr, while consolidated net profit attributable to owners fell 5.2% QoQ to ₹505.50 Cr (from ₹590.88 Cr) and rose 11.7% YoY from ₹452.55 Cr. The Board also declared an interim dividend of ₹3.50 per equity share (350% on ₹1 face value) for FY2026-27, with a record date of November 10, 2026 and payment from November 25, 2026.

  • · Consolidated profit before tax was ₹645.52 Cr in Q2 FY27, down from ₹755.65 Cr in Q1 FY27 (-14.6% QoQ) but up from ₹573.02 Cr in Q2 FY26 (+12.7% YoY).
  • · Total consolidated expenses rose 12.0% YoY in Q2 FY27 to ₹3,089.14 Cr, with 'Others' other expenses up 23.6% YoY to ₹504.62 Cr, while cost of materials consumed (including excise duty) rose 3.8% YoY to ₹1,442.99 Cr.
  • · Advertisement and publicity spend in Q2 FY27 was ₹226.59 Cr, roughly flat versus ₹233.57 Cr in Q2 FY26 (-3.0% YoY) and slightly down QoQ from ₹229.46 Cr.
  • · Finance costs rose to ₹39.59 Cr in Q2 FY27 from ₹39.68 Cr in Q2 FY26 (essentially flat YoY) and ₹36.63 Cr in Q1 FY27 (+8.1% QoQ).
  • · Non-controlling interest swung to a loss of ₹(6.93) Cr in Q2 FY27 in total comprehensive income, versus a profit of ₹16.93 Cr in net profit attributable to non-controlling interest, reflecting a loss from other comprehensive income in the period.
  • · Total other comprehensive income/(loss) for Q2 FY27 was ₹(23.57) Cr, a reversal from ₹72.58 Cr in Q2 FY26 and ₹(49.95) Cr in Q1 FY27.
  • · Statutory auditor G Basu & Co issued an unmodified opinion on the consolidated results; the joint venture's interim financials were unreviewed and deemed immaterial to the Group.
  • · Interim dividend record date is Tuesday, November 10, 2026, and payment begins November 25, 2026.
Dabur India Limited Corporate Action mixed materiality 8/10

04-11-2026

Dabur India Limited's Board approved unaudited consolidated and standalone results for the quarter and half year ended September 30, 2026, with an unmodified limited review report from G Basu & Co. Consolidated revenue from operations for Q2 FY27 was ₹3,563.07 Cr, up 11.6% YoY but down 5.3% QoQ from ₹3,764.39 Cr, while consolidated net profit attributable to owners fell 2.7% QoQ and rose 11.7% YoY to ₹505.50 Cr. The Board also declared an interim dividend of ₹3.50 per equity share (350% on ₹1 face value) with a record date of November 10, 2026 and payment from November 25, 2026.

  • · Interim dividend of ₹3.50 per share (350%) declared for FY 2026-27; record date November 10, 2026; payment from November 25, 2026
  • · Consolidated finance costs rose to ₹39.59 Cr in Q2 FY27 from ₹36.63 Cr in Q1 FY27, and ₹39.68 Cr in Q2 FY26 was flat YoY
  • · Quarterly 'Others' other expenses rose 23.6% YoY to ₹504.62 Cr, while advertisement and publicity spend fell 3.1% YoY to ₹226.59 Cr
  • · Half-year consolidated profit before tax of ₹1,401.17 Cr grew 13.4% YoY from ₹1,235.64 Cr
  • · Joint venture (Forum I Aviation) share of loss was ₹0.30 Cr in Q2 FY27 and ₹0.80 Cr for H1 FY27, unreviewed by its auditor and stated as immaterial to the Group
  • · Total comprehensive income attributable to owners fell 8.2% YoY in Q2 FY27 to ₹481.93 Cr due to a swing in other comprehensive income
  • · Statutory auditor G Basu & Co issued an unmodified limited review report on both consolidated and standalone results
Dabur India Limited Market Notice neutral materiality 7/10

04-11-2026

Dabur India's Board approved a leadership reshuffle on November 4, 2026: Global CEO and Whole-time Director Mohit Malhotra resigns effective November 13, 2026, with Herjit Singh Bhalla appointed as Additional and Whole-time Director from November 14, 2026 for five years (subject to approvals), and Gopal Krishna Jain proposed as a Non-Executive Independent Director for December 31, 2026 to December 30, 2028 (subject to postal ballot). Compliance Officer Ashok Kumar Jain superannuates on November 30, 2026, with CFO Ankush Jain designated as Compliance Officer from December 1, 2026.

  • · Malhotra's resignation letter states he has accepted a leadership role overseas effective November 16, 2026, and asked to be relieved before that date, which differs from the November 13, 2026 effective date in the filing
  • · Herjit Singh Bhalla joined Dabur earlier in 2026 after over 16 years at Unilever and experience at The Hershey Company and METRO cash & carry India
  • · Gopal Krishna Jain is a designated Senior Advocate with expertise in constitutional law, arbitration and regulatory advisory
  • · Mukesh Hari Butani's term as Independent Director ends December 31, 2026, and Romesh Sobti takes over as Lead Independent Director from January 1, 2027
  • · Ankush Jain is a qualified Chartered Accountant and Company Secretary (Membership No. ACS 18053) overseeing accounting, treasury, M&A, tax and internal audit globally
  • · The changes are disclosed for both listed equity shares and listed non-convertible debentures
Dabur India Limited Market Update neutral materiality 2/10

04-11-2026

Dabur India Limited's Board, on the recommendation of the Audit Committee, appointed Ernst & Young LLP as Joint Internal Auditors alongside PricewaterhouseCoopers Services LLP for the period November 04, 2026 to March 31, 2028. The disclosure is an administrative governance update under Regulation 30 of the SEBI Listing Regulations and contains no financial results or quantitative figures.

  • · EY is described as one of the largest enterprise Risk & Internal Audit firms in India and globally, with a focused FMCG & Consumer team.
  • · The internal audit engagement runs until March 31, 2028.
Dabur India Limited Market Notice mixed materiality 6/10

04-11-2026

Dabur India's Board approved a leadership reshuffle: Global CEO and Whole-time Director Mohit Malhotra resigned effective November 13, 2026 (overseas role from November 16), Herjit Singh Bhalla was appointed Additional and Whole-time Director from November 14, 2026 for five years subject to approvals, and Gopal Krishna Jain was appointed Non-Executive Independent Director for 2026-2028 subject to postal ballot. Ashok Kumar Jain superannuates on November 30, 2026, with CFO Ankush Jain becoming Compliance Officer from December 1, 2026. The filing is largely governance and leadership change with no reported financial metrics.

  • · Malhotra's resignation is effective November 13, 2026 per the Board outcome, though his letter states an overseas role effective November 16, 2026 and requests earlier relief.
  • · Romesh Sobti takes over as Lead Independent Director from January 1, 2027, replacing Mukesh Hari Butani whose term ends December 31, 2026.
  • · Gopal Krishna Jain and Herjit Singh Bhalla appointments require shareholder approval via postal ballot; timelines not yet communicated.
  • · Ankush Jain, a qualified Company Secretary (ACS 18053), takes over the Compliance Officer role from December 1, 2026 while remaining CFO.
  • · P. D. Narang retains Whole-time Director role with oversight of the International business.
Dabur India Limited Market Update mixed materiality 7/10

04-11-2026

Dabur India Limited's Board, at its November 4, 2026 meeting, accepted the resignation of Global CEO and Whole-time Director Mohit Malhotra effective November 13, 2026 (he is leaving for an overseas role effective November 16). It appointed Herjit Singh Bhalla, CEO-India Business, as Additional and Whole-time Director from November 14, 2026, and Gopal Krishna Jain as a Non-Executive Independent Director for December 31, 2026 to December 30, 2028, both subject to shareholder approval by postal ballot. Ankush Jain, the current CFO, will take over as Compliance Officer from December 1, 2026, after Ashok Kumar Jain superannuates on November 30, 2026.

  • · Mr. Malhotra's resignation letter cites a leadership role overseas effective November 16, 2026, with a request for the Board to relieve him before that date
  • · Mr. Narang, a Dabur veteran since 1983, retains strategic guidance across Group businesses and oversight of the International business
  • · Mr. Ankush Jain holds ACS membership number 18053 and will hold both the CFO and Compliance Officer roles
  • · Disclosures cover both listed equity shares and listed non-convertible debentures
  • · Postal ballot process, timelines, and details will be communicated later
Dabur India Limited Market Notice neutral materiality 7/10

04-11-2026

Dabur India's Board approved a leadership reshuffle on November 4, 2026: Global CEO and Whole-time Director Mohit Malhotra resigns effective November 13, 2026, while Herjit Singh Bhalla (CEO-India Business) is appointed Additional Director and Whole-time Director from November 14, 2026 for five years, subject to approvals. Gopal Krishna Jain is proposed as a Non-Executive Independent Director (Dec 31, 2026 to Dec 30, 2028, subject to postal ballot), Romesh Sobti becomes Lead Independent Director from January 1, 2027, and CFO Ankush Jain takes over as Compliance Officer from December 1, 2026 after Ashok Kumar Jain superannuates on November 30, 2026.

  • · Malhotra's resignation letter states he has accepted an overseas leadership role effective November 16, 2026 and asked to be relieved before that date, which differs from the November 13, 2026 effective date in the filing body.
  • · Mr. P. D. Narang continues as Whole-time Director with oversight of the International business.
  • · Bhalla's appointment and Gopal Krishna Jain's appointment both remain subject to shareholder approval via postal ballot, with timelines not yet communicated.
  • · Ankush Jain is a qualified Company Secretary (Membership No. ACS 18053) and will hold both CFO and Compliance Officer roles.
  • · Changes are disclosed for both listed equity shares and listed non-convertible debentures.
Dabur India Limited Market Notice mixed materiality 7/10

04-11-2026

Dabur India Limited reported Q2 FY27 consolidated revenue of ₹3,563 Crore, up 11.6% YoY, and Q2 net profit (PAT) of ₹505 Crore, up 11.7% YoY, marking the fourth consecutive quarter of double-digit profit growth. H1 revenue reached ₹7,327 Crore (+11.1%) and H1 PAT ₹1,096 Crore (+13.4%). The Board also declared an interim dividend of ₹3.50 per share, aggregating ₹620.88 Crore. Growth was mixed across segments: Healthcare grew a comparatively modest 6.9%, while International business grew 20% in INR terms.

  • · Healthcare (6.9%) was the slowest-growing major segment, trailing the company-wide Q2 revenue growth of 11.6%.
  • · General Trade channel resurged to mid-to-high single-digit growth in the quarter.
  • · Interim dividend of ₹3.50 per share declared for FY 2026-27.
  • · Premium brands grew at 4x the pace of regular brands and now make up 20% of the domestic business.
  • · Shampoo and Hair Oils grew at high double digits; Home Care also grew at double digits; Skin & Salon grew at high single digits; Oral Care grew at mid-single digits.
Godrej Consumer Products Limited Analyst/Investor Meet mixed materiality 7/10

04-11-2026

Godrej Consumer Products reported Q2 FY27 consolidated revenue growth of 19% YoY (15% in constant currency) with 8% underlying volume growth, EBITDA growth of 12%, and net profit growth of 14% to INR523 crore. Standalone sales grew 13% on 7% underlying volume growth despite an estimated 150 bps impact from trade inventory correction, while Personal Care value growth of 8% lagged on soap price-led recalibration and weaker soap volumes. Management held FY27 guidance of high single-digit underlying volume growth standalone and double-digit revenue and EBITDA growth consolidated, while flagging elevated commodity inflation in Q3 versus Q2.

  • · Management attributed the Personal Care softness to trade inventory correction (largest SKUs), soap price-volume recalibration, and industry price increases in soaps and detergents with margins still below normative levels.
  • · Management expects commodity inflation to be mildly higher in Q3 than Q2; the company will focus on EBITDA YoY growth rather than EBITDA margin percentages.
  • · Management said the India CEO search is underway, prioritizing Godrej values and entrepreneur mindset over speed of appointment.
  • · Godrej Spic has gone national after success in Tamil Nadu; pet care remains in pilot with a fuller update expected next quarter.
  • · Indonesia benefited from El Nino weather tailwinds that increased mosquito infestation; management called out a few basis points of this year's growth as weather-driven.
  • · Management said commodity inflation impact on India and Indonesia was approximately high single digit, mitigated by pricing, cost savings, and media optimization.
Hindustan Unilever Limited Analyst/Investor Meet mixed materiality 7/10

04-11-2026

Hindustan Unilever reported a September 2026 quarter with Turnover of Rs. 18,071 crore, 15% Underlying Sales Growth (USG) and 7% Underlying Volume Growth (UVG), its strongest USG in 14 quarters. PAT before exceptional items grew 9% to Rs. 2,795 crore, but reported PAT was flat year-on-year because of a one-off tax-related gain of Rs. 273 crore in the base period. Gross margin contracted roughly 400 basis points and EBITDA margin fell 140 basis points to 22.6%, with management attributing the gap to a lag between input-cost inflation and pricing; Home Care EBIT growth also moderated, while Health & Wellbeing and Oral Care were subdued.

  • · Gross margin contracted roughly 400 basis points YoY while EBITDA margin fell 140 basis points, with management citing about 260 basis points of offset from overheads and A&P operating leverage
  • · Home Care A&P was cut by about Rs. 250 crore in the quarter while spend rose in other categories
  • · Management reiterated a medium-term EBITDA margin range of 22% to 24%, expanded by 50 bps on either side from prior guidance
  • · Interim dividend of Rs. 19 per share declared for FY27
  • · Health & Wellbeing (OZiva) and Oral Care grew subdued; Oral Care at low-single digits
  • · Mass tea was softer due to inflation-driven pricing; Lifebuoy performance remains a weak point
  • · Management expects roughly 10% A&P savings from non-working media, AI tools and buying efficiency
Hindustan Unilever Limited Market Update neutral materiality 4/10

04-11-2026

Hindustan Unilever Limited's Board has proposed seeking shareholder approval via Postal Ballot to revise the annual aggregate remuneration limit for Non-Executive Directors for five years (April 1, 2026 to March 31, 2031). The proposed cap is ₹15 crore per annum or 1% of Net Profits, whichever is lower. The voting process is scheduled to conclude on December 17, 2026, with results declared by December 19, 2026.

  • · Remuneration revision covers the period April 1, 2026 to March 31, 2031 (five years)
  • · Cut-off date for member voting eligibility is November 6, 2026
  • · Electronic voting runs from November 18, 2026 to December 17, 2026
  • · Board resolution authorizing the postal ballot process was dated October 28, 2026
  • · Notice dispatch to members to be completed by November 13, 2026; newspaper advertisement on November 16, 2026
  • · Minutes signing deadline by the Chairman is January 15, 2027

Get daily alerts with 10 investment signals, 8 risk alerts, 7 opportunities and full AI analysis of all 22 filings

₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: BSE FMCG Sector Regulatory Filings

🇮🇳 More from India

View all →